Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom

BACKGROUND: Characteristics of patients using newer 2(nd) and 3(rd) line antidiabetic drugs in a real-world setting are poorly understood. We described the characteristics of new users of sodium-glucose co-transporter-2 inhibitors (SGLT-2i), dipeptidyl peptidase-4 inhibitors (DPP-4i), and glucagon-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunetti, Vanessa C., St-Jean, Audray, Dell’Aniello, Sophie, Fisher, Anat, Yu, Oriana H. Y., Bugden, Shawn C., Daigle, Jean-Marc, Hu, Nianping, Alessi-Severini, Silvia, Shah, Baiju R., Ronksley, Paul E., Lix, Lisa M., Ernst, Pierre, Filion, Kristian B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520836/
https://www.ncbi.nlm.nih.gov/pubmed/36175881
http://dx.doi.org/10.1186/s12902-022-01140-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520836/
https://www.ncbi.nlm.nih.gov/pubmed/36175881
http://dx.doi.org/10.1186/s12902-022-01140-1

Ejemplares similares